Cargando…
LRG1 promotes angiogenesis by modulating endothelial TGFß signalling
Aberrant neovascularisation contributes to diseases such as cancer, blindness and atherosclerosis and is the consequence of inappropriate angiogenic signalling. While many regulators of pathogenic angiogenesis have been identified, our understanding of this process is incomplete. Here we explored th...
Autores principales: | Wang, Xiaomeng, Abraham, Sabu, McKenzie, Jenny A.G., Jeffs, Natasha, Swire, Matthew, Tripathi, Vineeta B., Luhmann, Ulrich F.O., Lange, Clemens A.K., Zhai, Zhenhua, Arthur, Helen M., Bainbridge, James, Moss, Stephen E., Greenwood, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836402/ https://www.ncbi.nlm.nih.gov/pubmed/23868260 http://dx.doi.org/10.1038/nature12345 |
Ejemplares similares
-
GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides
por: Margheri, Francesca, et al.
Publicado: (2012) -
LRG1: an emerging player in disease pathogenesis
por: Camilli, Carlotta, et al.
Publicado: (2022) -
LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022) -
Correction: LRG1 as a novel therapeutic target in eye disease
por: De Rossi, Giulia, et al.
Publicado: (2022) -
Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022)